Ask Warren

Korea Pharma

032300 · KOSDAQ · ₩032300 · 한국파마

₩7,770▼ ₩30 (0.38%)End-of-day · Oct 30, 2026 · End-of-day prices.
Trade
Alert me
SellBuy
AnnualQuarterly

Income statement

Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024
Revenue₩26B₩25B₩19B₩24B₩23B₩21B₩22B₩19B
Cost of sales₩16B₩16B₩14B₩15B₩15B₩12B₩13B₩11B
Gross profit₩10B₩9.1B₩5.7B₩8.7B₩8.1B₩8.9B₩9.3B₩8.3B
Operating income₩2.2B₩1.3B−₩2.3B₩507M₩83M₩831M₩1.9B₩1.1B
Net income₩641M₩682M−₩2.6B₩355M−₩890M₩515M₩2.5B₩88M
Net income to shareholders₩641M₩682M−₩2.6B₩355M−₩890M₩515M₩2.5B₩88M

Balance sheet

Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024
Total assets₩131B₩130B₩127B₩129B₩127B₩117B₩112B₩112B
Current assets₩69B₩68B₩64B₩72B₩69B₩77B₩74B₩76B
Cash and equivalents₩28B₩29B₩28B₩28B₩20B₩23B₩22B₩32B
Total liabilities₩57B₩61B₩58B₩58B₩56B₩46B₩41B₩40B
Current liabilities₩43B₩60B₩57B₩42B₩40B₩22B₩19B₩18B
Borrowings₩29B₩38B₩38B₩37B₩36B₩23B₩23B₩22B
Total equity₩74B₩69B₩69B₩71B₩71B₩71B₩71B₩72B
Shareholders' equity₩74B₩69B₩69B₩71B₩71B₩71B₩71B₩72B

Cash flow

Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024
Cash from operations₩2.9B₩2.3B−₩245M₩3.4B−₩886M₩428M₩2.3B₩1.9B
Capital spending₩101M₩39M₩150M₩263M₩108M₩730M₩2.3B₩247M
Free cash flow₩2.8B₩2.3B−₩395M₩3.1B−₩994M−₩302M₩70M₩1.7B
Dividends paid₩1.1B−₩545M₩0₩0₩0₩545M₩0₩0

Consolidated where available. Amounts in won.

Also known as: Korea Pharma / 한국파마 / 032300 / KRX:032300

Source: KRX statistical information